Mankind Pharma prescription share: Proven growth with 50 US products
Mankind Pharma prescription share is growing, reporting a 15.2% share as it launches 50 products…
Tag: pharmaceuticals
Cancer drug price cap: Is it the best move for patients?
Cancer drug price cap leads to a 70% reduction in costs, benefiting patients. Discover how…
Drug price caps: The Wrong Approach to Cancer Treatment
Drug price caps are crucial, but the focus must extend beyond cancer drugs for better…
Cancer drug prices may fall: A clear path to affordability
Cancer drug prices may soon drop significantly, making treatments more accessible for patients.
Is Lantheus Bravnetsa Approval a Safe and Proven Option?
Lantheus Bravnetsa approval marks a significant advancement in treatment options. Discover its implications and benefits.
Is Somatuline Generic Approval the Worst News for Ipsen?
Somatuline generic approval has led to a 7% drop in Ipsen's stock. What does this…
Bayer lung cancer drug approval: Safe and Proven Solution
Bayer lung cancer drug approval expands treatment options for patients.